IXO Private Equity

IXO Private Equity

A private equity firm in France that focuses on investing in the consumer goods, information technology, biotechnology, healthcare, transportation, chemicals, and healthcare sectors

IXO Private Equity is a private equity firm in France that focuses on investing in the consumer goods, information technology, biotechnology, healthcare, transportation, chemicals, and healthcare sectors. Founded 1981 in Toulouse, Midi-Pyrenees, France, it invests in early stage ventures, late stage ventures, and private equity. As of February 2020, IXO Private Equity has made 23 investments. Their most recent investment was on September 11, 2018, when iskn raised €10.5M. IXO Private Equity has had four exits, the most notable of which include SuperSonic Imagine, Scoop.it, and Advicenne. The company has raised two funds, their latest being IXO Fund IV. This fund was announced on January 15, 2019 and raised a total of €200M.

Timeline

1981

Founded

Funded Companies

Company
Description
Industry
Website
Location
Sigfox

French company that builds wireless networks

4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Alexandre Sagon

Associate Director

Andre Debet

Business Manager

Baptiste Martin-Wurmser

Director of Front Office participation

Bruno De Cambiaire

President

Francois Sion

Business Manager

Hasnaa Hafid

Director of Front Office participation

Jean-Luc Riviere

Associate Director

Marie-Laure Joubard

Business Manager

Nicolas Charleux

Associate Director

Nicolas Olives

Director of Front Office participation

Olivier Athanase

General Manager

Pierre-Yves Francois

Business Manager

Remi Cheriaux

Director of Front Office participation

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

1Life

Advicenne

Antabio

Caléa

Care Labs

Fleuret

iskn

Ixaltis

Rider Valley

SIGFOX

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.